1. What data in particular will be shared?
   Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   
   
3. Who will be able to view these files?
   Response - Researchers who provide a methodologically sound proposal.
   


4. For what types of analyses will this data be available?
   Response - To achieve aims in the approved proposal.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [kalaipalanivel159@gmail.com].
   


6. For how long will this data be available start date provided 13-11-2026 and end date provided 13-11-2031?
   Response - Beginning 3 months and ending 5 years following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - nil

AIM:

To evaluate the effectiveness of individualized Homoeopathic medicines in improving the quality of life in dementia patients.

 OBJECTIVES

To assess the impact of individualized Homoeopathic medicine on the quality of life in dementia patients.

To measure the changes in memory, emotional wellbeing, daily activities using DEMQOL questionnaire before and after treatment

To identify the most used Homoeopathic medicines for dementia

BACKGROUND AND JUSTIFICATION

Dementia is a progressive neurodegenerative disorder marked by a decline in cognitive function, memory, language, and the ability to perform everyday activities. It primarily affects the elderly population and is associated with a significant deterioration in quality of life both for the individual and their caregivers .Despite the availability of conventional pharmacological treatments, these often provide only symptomatic relief and are frequently accompanied by side effects, especially in elderly individuals with multiple comorbidities. While there is small scale studies have reported improvement in symptoms and over all wellbeing in dementia patients using individualized homoeopathic medicine, there is a lack of structured clinical evidence evaluating its impact on quality of life using validated scale like DEMQOL. This study aim to play a role on improving overall wellbeing in dementia patients.

METHODOLOGY

The study will be conducted with clinically diagnosed 40 cases of dementia will be selected based on inclusion and exclusion criteria for the study. Diagnostic screening will be done by Montreal Cognitive Assessment. The cases will be analyzed and the totality of symptoms will be erected based on Homoeopathic philosophy to arrive the suitable remedy for each patient. Then the individualized Homoeopathic medicine will be prescribed with the proper dose, potency, and repetitions. Follow up will be taken once in a month to assess the improvement in quality of life among dementia patients. Pre assessment and post assessment of Dementia Quality of Life DEMQOL will be taken three months once to evaluate the quality of life in dementia patients.